No abstract available
MeSH terms
-
Antiviral Agents / therapeutic use*
-
Cytomegalovirus Infections / diagnosis
-
Cytomegalovirus Infections / prevention & control*
-
Female
-
Follow-Up Studies
-
Ganciclovir / therapeutic use*
-
Heart Transplantation / adverse effects*
-
Humans
-
Male
-
Patient Selection
-
Phosphoproteins / blood*
-
Postoperative Complications / prevention & control
-
Postoperative Complications / virology
-
Prospective Studies
-
Time Factors
-
Viral Matrix Proteins / blood*
Substances
-
Antiviral Agents
-
Phosphoproteins
-
Viral Matrix Proteins
-
cytomegalovirus matrix protein 65kDa
-
Ganciclovir